SWELIFE CALL IN WIDESPREAD DISEASES Karin Agerman

Transcription

1 SWELIFE CALL IN WIDESPREAD DISEASES Karin Agerman

2 Strategic innovation areas To meet global competition and to help solve global societal challenges Cross-border collaboration for renewal of Swedish areas of strength Stakeholders set the strategic agenda to meet their needs Mobilization of resources and knowledge Long-term investment Open for all

3 Programs Smartare elektroniksystem Grafen Internet of Things Digitalisation Cutting edge solutions Produktion2030 Automatiserade transportsystem Metalliska material Gruv- och metallutvinning Lättvikt Medtech4health Finansmarknad PiiA Innovair FFI SWElife Lifescience for health Re:Source Smart Built Systems INFRASweden2030 BioInnovation Sustainable society Bygginnovationen

4

5 What is SWElife? SWElife is a long-term investment aiming to strengthen the Swedish Life Science sector SWElife will optimize the use of existing competence and infrastructure through collaboration between sectors and between different regions Broad commitment and active involvement from organizations in all sectors and regions in Sweden Continuous expansion and inclusion of new partners

6 SWElife at a glance Innovation Programme for Life Science SWElife Arena - collaboration support Expert networks Mappings, benchmarking & sharing of best practice Documents and templates Meeting places IRL and Virtual Need- driven, na,onal, cross- sectorial, promote collabora,on and innova,on Communication and PR Competences, Capabilities & Capital Funding through calls at VINNOVA So far, 25 projects within the area Widespread Diseases (folksjukdomar) SME support for early verification activities SWElife Hands-on New model for step-by-step support New model for private/public venture capital Clinical Innovation and Transformation Creation of nation-wide cohorts standardized routines for blood sampling Clinical informatics aims at delivering an evidence based decision support tool to individual doctors, based on the wealth of available information Digital health project: research needs from health care informatics Personalized medicine implementation of national guidelines for biomarkers E-Learning modules Clinical trial methodology

7 New open call from SWElife (& VINNOVA) - widespread diseases What? Collaborative innovation projects that lead to better health in the field of widespread diseases or any risk factors and complications from widespread diseases. Who? Consortia of at least 2 partners from academia/researchers, health care, companies (health care need to have an active role) How much? Up to 1 million SEK for 1 year in step 1 Up to 5 million SEK for 2 years in step 2 50 % co-funding is required in both steps When? Call is open Deadline for applications February 2nd NB. Cannot apply for MedTech4Health call opening 29th of Jan with same project More info/apply: swelife.se/calls

8 How do we work in SWElife Hands-on - National network of regional co-ordinators of innovation actors SWElife - C3 Koordinator Koordinator Koordinator Koordinator Koordinator Koordinator Regional co-ordinators: Lund Lunds Life Science Incubator Göteborg Sahlgrenska Science Park Linköping LiU Innovationskontor Stockholm Karolinska Institutet Innovation Office Uppsala Uppsala BIO Umeå Umeå Biotech Incubator

9 SWElife Hands-on model - Strengthening innovation projects Model for SWElife calls to strenghten the quality of innovation projects and their possibilities for follow-up funding Main activities in the SWElife hands-on model: Support and input during application Mini due diligence in selection phase Sounding board to excel project in execution phase Feedback on applications and support for new funding

10 Proposals within scope Projects that aim to develop new methods of prevention, treatment or relief for people who are at risk for or already suffer from any widespread disease. Projects applying for funding must fulfil the three criteria below: Innovative build on new knowledge and contain a significant amount of risk Growth-inducing - contribute to growth of companies or create significant quality improvement within public healthcare, and for the patient Application-oriented solve a problem/need of both national and global importance as well as have a clear implementation plan for the solution (e.g. within public healthcare)

11 Widespread diseases A widespread disease (folksjukdom) is defined as a disease or a disease-group with prevalence in the population exceeding 1%. Diseases of mild character and/or short duration are not included. Examples of diseases that are covered in this call are: diabetes type 2 cardiovascular diseases obesity cancers autoimmune disorders (e.g. diabetes type 1, rheumatoid arthritis SLE) dementia and other age dependent neurological diseases mental illness chronic pain musculoskeletal diseases (e.g. osteoporosis) asthma, allergies and the lung disease COPD (covering chronic bronchitis and emphysema)

12 Important dates SWElife Hands-on model Feedback on applications: deadline 18 January 2016 Application deadline 2 February 2016 at 14:00 SWElife Hands-on model Support for projects selected for interview: week Planned dates for interviews 9 20 May 2016 Last day to start the project 17 June 2016

13 Get help SWElife Hands-on modell Application Selection Feedback on rejected projects Implementation Drug discovery projects Contact the SciLifeLab Drug Discovery & Development platform

14 CONTACT YOUR LOCAL CO-ORDINATOR Lund Sarah Fredriksson Göteborg Göran Leonardsson Linköping Ali Moshfegh Stockholm Bo-Ragnar Tolf , Uppsala Anna Ridderstad Wollberg, anna.ridderstad.wollberg@uppsalabio.se, Umeå Helén Fält helen.falt@ubi.se, SWElife Karin Agerman karin.agerman@swelife.se,

15 Thanks Links: Utlysningar/Effekta/SWElife---Innovativasamverkansprojekt-inom-folksjukdomar /